Tobacco and Public Health - TCSC Indonesia

BRIDGETTE E. GARRETT ET AL. 163
Gommans, J., Stolerman, I. P., and Shoaib, M. (2000). Antagonism of the discriminative and aversive
stimulus properties of nicotine in C57BL/6J mice. Neuropharmacol, 39, 2840–7.
Grottick, A. J., Trube, J., Corrigall, W. A., Huwyler, J., Malherbe, P., Wyler, R., et al. (2000). Evidence
that nicotinic α7 receptors are not involved in the hyperlocomotor and rewarding effects of
nicotine. J Pharmacol Exp Ther, 294, 1112–19.
Henningfield, J. E., Miyasato, K., and Jasinski, D. (1983). Cigarette smokers self-administer intravenous
nicotine. Pharmacol Biochem Behav, 19, 887–90.
Henningfield, J. E. (1984). Behavioral Pharmacology of Cigarette Smoking. In: Thompson T, Dews
PB and Barrett JE editors. Advances in Behavioral Pharmacology,Vol. IV. New York: Academic
Press, pp. 131–210.
Henningfield, J. E., Miyasato, K., Jasinski, D. R. (1985). Abuse liability and pharmacodynamic
characteristics of intravenous and inhaled nicotine. J Pharmacol Exp Ther, 234, 1–12.
Henningfield, J. E. and Keenan, R. (1993). Nicotine delivery kinetics and abuse liability. Journal of
Consulting Clin Psychol, 61, 743–50.
Henningfield, J. E., Stapleton, J. M., Benowitz, N. L., and London, E. D. (1993). Higher levels of
nicotine in arterial than in venous blood after cigarette smoking. Drug Alcohol Depend, 33, 23–9.
Henningfield, J. E. and Zeller, M. (2003). Could science-based regulation make tobacco products less
addictive. Yale Journal of Health Policy,Law and Ethics, in press.
Horan, B., Smith, M., Gardner, E. L., Lepore, M., and Ashby, C.R. (1997). Nicotine produces
conditioned place preference in Lewis, but not Fischer 344 rats. Synapse, 26, 93–4.
Jasinski, D. R. and Henningfield, J. E. (1989). Human abuse liability assessment by measurement of
subjective and physiological effects. In: Fischman MW, Mello NK, ed. Testing for abuse
liability of drugs in humans. NIDA Research Monograph 92. Washington (DC): US Government
Printing Office, pp. 73–100.
Jones, H. E., Garrett, B. E., and Griffiths, R. R. (1999). Subjective and physiological effects of
intravenous nicotine and cocaine in cigarette smoking cocaine abusers. J Pharmacol Exp Ther,
288, 18–197.
Jorenby, D. E., Steinpreis, R. E., Sherman, J. E., and Baker, T. B. (1990). Aversion instead of preference
learning indicated by nicotine place conditioning in rats. Psychopharmacol, 101, 533–8.
Katz, J. L. (1990). Models of relative reinforcing efficacy of drug and their predictive utility. Behav
Pharmacol, 1, 283–301.
Kempsill, F. E. J. and Pratt, J. A. (2000). Mecamylamine but not the α7 receptor antagonist
α-bungarotoxin blocks sensitization to the locomotor stimulant effects of nicotine.
Br J Pharmacol, 131, 997–1003.
Kessler, D. (2000). A Question of Intent: A Great American Battle with a Deadly Industry. New York:
Public Affairs.
Koob, G. F. (1992). Neural mechanisms of drug reinforcement. Ann NY Acad Sci, 564, 171–91.
Klink, R., de Kerchove d’Exaerde, A., Zoli, M., and Changeux, J. P. (2001). Molecular and physiological
diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J Neurosci, 21,
1452–63.
Ksir, C. (1994). Acute and chronic nicotine effects on measures of activity in rats: a multivariate
analysis. Psychopharmacol, 15, 105–9.
Lanca, A. J., Sanelli, T. R., and Corrigall, W. A. (2000). Nicotine-induced fos expression in the
pedunculopontine mesencephalic tegmentum in the rat. Neuropharmacol, 39, 2808–17.
Lindblom, N., De Villiers, S. H., Kalayanov, G., Gordon, S., Johansson, A. M., and Svensson, T. H.
(2002). Active immunization against nicotine prevents reinstatement of nicotine seeking behavior
in rats. Respiration, 69, 254–60.